Embracing the Power of Generative AI in Clinical Research

In many respects, the arrival of generative artificial intelligence (AI) represents an entirely expected ...

How to Modernize Clinical Trials to Promote Enhanced Patient Diversity and Access

An initial and discernible benefit to adopting decentralized clinical trial (DCT) models is alleviating ...

Improving Rare Disease Clinical Trial Design

According to the National Organization for Rare Disorders (NORD), there are over 7,000 known ...

Making Clinical Trials Better for Everyone in 2023

Getting clinical trials to the finish line is not easy. Between 15% to 40% ...

Two Key Questions About Clinical Trials in 2023

PM360 asked experts in clinical trials about the evolution of decentralized research and what ...

What Does It Take to Design a Patient-centric Clinical Trial Protocol?

Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...

Evolution of ePROM: Advancements, Concerns, and the Way Forward

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...